The present invention relates to novel compounds of formulae (I) and (II) which are useful in the prevention, treatment and diagnosis, in vivo diagnosis of diseases or disorders related to S1P receptors, in particular, in diseases which are connected to the regulatory function of sphingosine-1-phosphate (S1P) and its analogs, such as inflammation, pain, autoimmune diseases and cardiovascular diseases.
本发明涉及式(I)和(II)的新化合物,其在预防、治疗和诊断与S1P受体相关的疾病或障碍,特别是与神经酰胺-1-
磷酸酯(S1P)及其类似物的调节功能相关的疾病,如炎症、疼痛、自身免疫疾病和心血管疾病的体内诊断方面具有用途。